[{"AccountsPayableCurrent_0_Q2_USD":53079000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":4198000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":32352000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":9880000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-9164000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":71633000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-248000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-247000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_2_Q2_USD":-116000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q2_USD":-58000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":7541000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":636000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2_Q2_USD":7674000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2_Q2_USD":7673000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":825000.0,"OtherAssetsNoncurrent_0_Q2_USD":34587000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":238089000.0,"OperatingLeasePayments_2_Q2_USD":19217000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":288559000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":39362000.0,"OperatingIncomeLoss_2_Q2_USD":-332414000.0,"OperatingIncomeLoss_1_Q2_USD":-146160000.0,"NonoperatingIncomeExpense_2_Q2_USD":-55192000.0,"NonoperatingIncomeExpense_1_Q2_USD":-42171000.0,"NetIncomeLoss_2_Q2_USD":-389850000.0,"NetIncomeLoss_1_Q2_USD":-189559000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-357516000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":228376000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":380988000.0,"LongTermDebt_0_Q2_USD":433151000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":514815000.0,"LiabilitiesCurrent_0_Q2_USD":554648000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":28424000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":117428000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":117772000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":75449000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q2_USD":7718000.0,"StockholdersEquity_0_Q2_USD":853362000.0,"ShareBasedCompensation_2_Q2_USD":87768000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":292182000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":145323000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":5309000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":398119000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":220553000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-4975219000.0,"RestrictedInvestmentsNoncurrent_0_Q2_USD":40890000.0,"RestrictedCash_0_Q2_USD":2298000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":368534000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":182635000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2_Q2_USD":133000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":470700000.0,"ProceedsFromSaleOfRestrictedInvestments_2_Q2_USD":10650000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":775978000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":128838000.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":0.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":250000000.0,"ProceedsFromDerivativeInstrumentFinancingActivities_2_Q2_USD":8400000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":94136000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"PaymentsToAcquireRestrictedInvestments_2_Q2_USD":10815000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":3509429000.0,"Liabilities_0_Q2_USD":2656067000.0,"InvestmentIncomeInterest_2_Q2_USD":859000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-382309000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-188923000.0,"CommonStockValue_0_Q2_USD":1186000.0,"CommonStockSharesOutstanding_0_Q2_shares":118596000.0,"CommonStockSharesIssued_0_Q2_shares":118596000.0,"CommonStockSharesAuthorized_0_Q2_shares":250000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":249019000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":748065000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":0.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":745767000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":11796000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":1101782000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":1101782000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":1101682000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":99000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":199000.0,"AssetsCurrent_0_Q2_USD":2725163000.0,"Assets_0_Q2_USD":3509429000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":13808000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":87768000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":32078000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":32928000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":5863476000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-36081000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":341187000.0,"AccountsReceivableNetCurrent_0_Q2_USD":146587000.0,"AccountsReceivableNet_0_Q2_USD":33932000.0,"ContractWithCustomerLiability_0_Q2_USD":82263000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":98144000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":202391000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":29200000.0,"InvestmentIncomeInterest_1_Q2_USD":409000.0,"InventoryWorkInProcess_0_Q2_USD":25311000.0,"InventoryRawMaterials_0_Q2_USD":54344000.0,"InventoryNet_0_Q2_USD":84358000.0,"InventoryFinishedGoods_0_Q2_USD":16453000.0,"InterestExpense_2_Q2_USD":65931000.0,"InterestExpense_1_Q2_USD":33416000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":30621000.0,"IncreaseDecreaseInInventories_2_Q2_USD":2021000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-51742000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":46020000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":2374000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":2244000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1228000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":117428000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-387606000.0,"EquitySecuritiesFvNiGainLoss_2_Q2_USD":42582000.0,"EquitySecuritiesFvNi_0_Q2_USD":52533000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-2829000.0,"EarningsPerShareDiluted_2_Q2_USD":-3.32,"EarningsPerShareDiluted_1_Q2_USD":-1.61,"EarningsPerShareBasic_2_Q2_USD":-3.32,"EarningsPerShareBasic_1_Q2_USD":-1.61,"DepreciationAmortizationAndAccretionNet_2_Q2_USD":24406000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q2_pure":0.15,"CostsAndExpenses_2_Q2_USD":730533000.0,"CostsAndExpenses_1_Q2_USD":366713000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":53279000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":30256000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":54500000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-188331000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":117772000.0,"Ticker":"ALNY","CIK":"1178670","name":"ALNYLAM PHARMACEUTICALS, INC.","OfficialName":"Alnylam Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"19459816074.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210803"}]